NPM1-MUTATED ACUTE MYELOID LEUKEMIA
Clinical trials for NPM1-MUTATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new NPM1-MUTATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for NPM1-MUTATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to keep leukemia away after transplant
Disease control Recruiting nowThis early-phase trial tests a drug called revumenib in people with acute leukemia who have had a stem cell transplant. The drug targets a protein that helps leukemia cells grow. The study will check safety, find the best dose, and see if it can stop the cancer from coming back. …
Matched conditions: NPM1-MUTATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study investigates why some AML patients face early bleeding or clotting risks
Knowledge-focused Recruiting nowThis observational study examines a specific group of patients with a type of acute myeloid leukemia (AML) that has an NPM1 mutation. Researchers want to see if a particular subset, called APL-like, is linked to early blood vessel problems like bleeding or clots. The study will l…
Matched conditions: NPM1-MUTATED ACUTE MYELOID LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC